CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Accumulated Other Comprehensive Loss	Accumulated Deficit
Beginning Balance at Dec. 31, 2021	$ 216,263	$ 4	$ 346,382		$ (130,123)
Beginning Balance, Shares at Dec. 31, 2021		37,174,741
Issuance of common stock upon vesting and exercise of stock options	247		247
Issuance of common stock upon vesting and exercise of stock options, Shares		161,573
Stock-based compensation expense	1,746		1,746
Other comprehensive income (loss)	(1,072)			$ (1,072)
Net loss	(22,737)				(22,737)
Ending Balance at Mar. 31, 2022	194,447	$ 4	348,375	(1,072)	(152,860)
Ending Balance, Shares at Mar. 31, 2022		37,336,314
Beginning Balance at Dec. 31, 2022	$ 250,607	$ 7	473,587	(770)	(222,217)
Beginning Balance, Shares at Dec. 31, 2022	65,996,138	65,996,138
Issuance of common stock upon vesting of RSUs and vesting and exercise of stock options, net of shares withheld for taxes	$ (340)		(340)
Issuance of common stock upon vesting of RSUs and vesting and exercise of stock options, , net of shares withheld for taxes, Shares		205,485
Issuance of common stock from open market sales agreeement	3,717		3,717
Issuance of common stock from open market sales agreeement, Shares		733,274
Stock-based compensation expense	4,068		4,068
Other comprehensive income (loss)	596			596
Net loss	(28,433)				(28,433)
Ending Balance at Mar. 31, 2023	$ 230,215	$ 7	$ 481,032	$ (174)	$ (250,650)
Ending Balance, Shares at Mar. 31, 2023	66,934,897	66,934,897